Page 62 - FINAL PROGRAM
P. 62
MONDAY, 4 JULY 2016
15:15 - 16:30 Room 101
Session 21: Poor responders: new hope?
15:30 O-081
15:30 O-082
15:45 O-083
16:00 O-084
16:15 O-085
The impact of total follicle-stimulating hormone (FSH) dose on outcomes in ESHRE Bologna poor ovarian responders. A post-hoc analysis of the ESPART randomized controlled trial
J. Hubbard (U.S.A.)
A randomised double blind placebo controlled study of recombinant human growth hormone (r-HGH) on live birth rates in women who are poor responders
R.J. Norman (Australia)
A prospective randomized controlled study depicting favourable IVF outcomes of pretreatment with Transdermal-Testosterone in Poor-Responders undergoing ART cycles M. Singh (India)
Dehydroepiandrosterone administration does not increase pregnancy rates in poor responders: a meta-analysis
E. Kolibianakis (Greece)
Elevated progesterone on the day of triggering nal oocyte maturation signi cantly predicts its reoccurrence in a subsequent IVF cycle
C. Venetis (Australia)
58
